PATENT CLAIM ANALYSIS

Application Number: 16225028
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-07
Patent Classification: ["424", "248100"]

Abstract:
The present invention provides an immunomodulator for use in the treatment and/or control of a neoplastic disease in a patient intended to undergo immunogenic cell death therapy simultaneously, separately or sequentially with administration of the immunomodulator. The therapy can be selected from microwave irradiation, targeted radiotherapy, embolization, cryotherapy, ultrasound, high intensity focused ultrasound, cyberknife, hyperthermia, radiofrequency ablation, cryoablation, electrotome heating, hot water injection, alcohol injection, embolization, radiation exposure, photodynamic therapy, laser beam irradiation, and combinations thereof.

Claim (Index 25):
A method for treating a tumour, or inhibiting or controlling development of a tumour in a patient, the method comprising:\n applying an ablative tumour disruption therapy to the tumour to induce damage to the tumour or one or more tumour cells and release of tumour antigens, wherein the ablative tumour disruption therapy is selected from the group consisting of ionizing radiation of the tumour, targeted radiotherapy of the tumour, radiofrequency ablation of the tumour, cryoablation of the tumour, laser ablation of the tumour, and microwave ablation of the tumour; simultaneously, separately, or sequentially with induction of damage to the tumour, administering to the patient by a parenteral route an immunomodulator composition consisting of non-pathogenic heat-killed whole cell  Mycobacterium obuense  in an amount effective to treat the tumour, or inhibit or control development of the tumour, wherein the parenteral route does not comprise intratumoral injection.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 98.0
- Lexical Diversity: 1.45455
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13396866', '16112430', '15104890', '15301793', '14138421']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7151282921512027
- 35 USC 102 Novelty (BERT): 0.5259223040722698
- Combined Prediction Score: 0.6962076933433093
- Mean Citation Score: 248.612132
- Max Citation Score: 334.79575
- Similarity Product: 216.1136314136684

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test